FluCrazy 200 - The 200 Largest Pharmaceutical Companies in the World

FluCrazy 200

Updated list for 2012 is here: 

http://flucrazy.blogspot.com/2012/03/flu-crazy-200-largest-pharmaceutical.html




2011
The 200 Largest Pharmaceutical Companies in the World

(Alphabetical Order)

Abbott Laboratories
Acrux Limited
Alexion
ALK-Abello AS
Alkermes
Allergan
Amarin Corporation plc
Amylin Pharmaceuticals
Ardea Biosciences
ARIAD Pharmaceuticals
Astellas Pharma Inc.
AstraZeneca Pharma India
Aurobindo Pharma
Auxilium
Bavarian Nordic A/S
Baxter International
Bayer
Beijing Double-Crane
Beijing Tongrentang Co
Biocon Limited
Biogen Idec
BioMarin Pharmaceutical
Boiron S.A.
Bristol-Myers Squibb
Cadila Healthcare
Celgene Corporation
Celltrion Inc
Cephalon
Chengdu Hoist
Chongqing Huapont Pharmaceutical
Chongqing Taiji Industry
Chugai Pharmaceutical
Cipla
Clinical Data Inc
Cubist Pharmaceuticals
Da An Gene Co Ltd of Sun Yat-Sen University
Daiichi Sankyo
Dainippon Sumitomo
Dendreon
Divi's Laboratories
Dong-A Pharmaceutical Co
Dr. Reddy's Laboratories
EGIS NyRt
Eisai
Eli Lilly
Emergent BioSolutions
Endo Pharmaceuticals
Enzon Pharmaceuticals
Euromayor S.A. De Inversiones
Exelixis
F. Reichelt AG
Financiere de Tubize
Forest Laboratories
Gansu Duyiwei Biological
Genomma Lab Internacional SAB de CV
Geron Corp
GlaxoSmithKline
Glenmark Pharmaceuticals
Green Cross Corp
Guangzhou Baiyunshan
Guangzhou Pharmaceutical
Guizhou Bailing Group
Guizhou Yibai
H. Lundbeck
Hainan Honz Pharmaceutical Co
Halozyme Therapeutics
Harbin Pharm Group Sanjing
Harbin Pharmaceutical
Henan Topfond Pharmaceutical
Hikma Pharmaceuticals
Hisamitsu
Hospira
Huadong Medicine Co
Hubei Biocause Pharmaceutical Co
ImmunoGen Inc
Impax Laboratories
Intermune, Inc.
IPCA Laboratories
Jazz Pharmaceuticals
Jiangsu Hengrui Medicine
Jiangsu Kanion Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Jiangsu Sihuan Bioengineering
Jiangxi Jiangzhong Pharmaceutical
Jilin Aodong Medicine
Jinling Pharmaceutical
Jiuzhitang Co
Kaken Pharmaceutical
Kangmei
King Pharmaceuticals (acquired by Pfizer, Inc)
Kissei Pharmaceutical
Kobayashi Pharmaceutical Co
Krka, tovarna zdravil
Kunming Pharmaceutical
Kyorin
Kyowa Hakko Kirin
Lexicon Pharmaceuticals
LG Life Sciences
Livzon
Lupin
Max India
MaYinglong Pharmaceutical
Medicines Company
Medicis Pharmaceutical
Merck
Merck KGaA
Merro Pharmaceutical
Mitsubishi Tanabe Pharma
Mochida Pharmaceutical
Momenta Pharmaceuticals
Mylan
Myriad Genetics
Nektar Therapeutics
Nichi-iko Pharmaceutical
Nippon Shinyaku Co
North China Pharmaceutical
Northeast Pharmaceutical
Novo-Nordisk
Ono Pharmaceutical
ONYX Pharmaceuticals
Opko Health Inc
Orion Oyj
Par Pharmaceutical
Perrigo
Pfizer (India)
Pfizer Inc.
Pharmasset
Pharmstandard JSC
Piramal Healthcare
PKU International
Prestige Brands Holdings
Protek OAO
PT Kalbe Farma
Qingdao Huaren Pharmaceutical
Q-Med AB
Questcor Pharmaceuticals
Ranbaxy Laboratories
Recordati
Regeneron Pharmaceuticals
Richter Gedeon Nyrt
Rohto Pharmaceutical
Salix
Sanofi-Aventis
Santen Pharmaceutical
Savient Pharmaceuticals
Sawai Pharmaceutical
Seikagaku Corp
Shandong Luoxin Pharmacy
Shanghai Fosun
Shanghai Kaibao Pharmaceutical
Shanghai Modern Pharmaceutical
Shanghai RAAS Blood Products
Shanxi Yabao Pharmaceutical
Shenzhen Accord
Shenzhen Salubris Pharmaceuticals Co
Shionogi
Shire PLC
Sichuan Kelun
SIGA Technologies
Simcere Pharmaceutical
Square Pharmaceuticals
STADA Arzneimittel
Stallergenes
Sun Pharmaceutical
Swedish Orphan Biovitrum AB
Taisho Pharmaceutical
Takeda Pharmaceutical
Targacept
Tempo Scan Pacific
Theravance
Tianjin Chase Sun Pharmaceutical
Tianjin Zhong Xin
Tibet Cheezheng Tibetan Medicine
Tibet Urban Development & Investment
Torii Pharmaceutical
Torrent Pharmaceuticals
Towa Pharmaceutical
Tsumura & Co.
TTY Biopharm
Unisplendour Guhan Group
United Therapeutics
Valeant Pharmaceuticals
Vertex
Virbac SA
ViroPharma
Vivus Inc
Watson Pharmaceuticals
Wockhardt
Xiangxue Pharmaceutical
Xinjiang Tecon Animal Husbandry Bio-Technology
YuHan Corp
Zeria Pharmaceutical
Zhangzhou Pientzehuang
Zhejiang Hisoar Pharmaceutical
Zhejiang Hisun
Zhejiang Huahai
Zhejiang Jianfeng Group
Zhejiang Medicine Co., Ltd.
Zhejiang Xianju Pharmaceutical
Zhuzhou Qianjin Pharmaceutical

Forest Lab's (NYSE: FRX) Teflaro "one to watch"

Forest Lab's (NYSE: FRX) Teflaro is listed as a phase III "one to watch" by Thomson Reuters Pharma.

Teflaro is used to treat bacterial pneumonia.

From the report: "Teflaro is an injectable formulation of the broad-spectrum antibiotic ceftaroline fosamil from Forest Laboratories, which acquired the worldwide rights to the drug after its acquisition of Cerexa in 2007. Teflaro received approval from the FDA in October 2010 for the treatment of community-acquired bacterial pneumonia (CABP), including those cases caused by multidrug-resistant Streptococcus pneumoniae, and skin and skin structure infections (SSSIs), including those caused by methicillin-resistant Staphylococcus aureus.
Both bacterial CABP and SSSI are serious, potentially life-threatening
conditions, and new treatments are needed constantly, particularly as
bacteria resistance to existing antibiotics continues to increase.
Phase III trials showed that Teflaro had a similar response and cure rate
to ceftriaxone in CABP patients and was as effective as vancomycin plus
aztreonam against SSSIs."

Also mentioned in the report:

Haleven, from Eisai (Metastatic breast cancer)

Kombiglyze XR, from AstraZeneca/Bristol Myers Squibb (Type 2 diabetes)

Brilique, from AstraZeneca (Acute coronary syndrome)

Ruconest, from Pharming/Esteve (Hereditary angioedema)


The full report is available at
http://thomsonreuters.com/content/science/pdf/ls/pharma_matters/the_ones_to_watch.pdf